ISBN-13: 9781941859414 / Angielski / Miękka / 2015 / 236 str.
ISBN-13: 9781941859414 / Angielski / Miękka / 2015 / 236 str.
Replete with intrigue, Inflection Point is the true story of the author and her legal team at Pfizer who found themselves at the epicenter of the decade long, world-wide, multi-billion battle for control over the world's most prescribed pharmaceutical product, Lipitor(r). The author charts the course of the team's courageous eff ort to protect the company's most prized asset, and the unforeseen personal consequences suffered as a result. In New York, London, Paris, Copenhagen, and Ottawa, from the White House to Wall Street, in boardrooms and courtrooms, in the media and behind closed doors, critical disputes are won and lost in a struggle for survival. Inflection Point is a fast-paced, high-stakes legal thriller and memoir. But it is also a cautionary tale posing a question as fundamental as it is critical: Have the efforts to bring affordable medicines to consumers helped to cripple the very industry that invents life-saving drugs in the first place?
Replete with intrigue, Inflection Point is the true story of the authorand her legal team at Pfizer who found themselves at the epicenterof the decade long, world-wide, multi-billion battle for control over theworlds most prescribed pharmaceutical product, Lipitor®. The authorcharts the course of the teams courageous eff ort to protect the companysmost prized asset, and the unforeseen personal consequences suffered asa result.In New York, London, Paris, Copenhagen, and Ottawa, from the WhiteHouse to Wall Street, in boardrooms and courtrooms, in the media andbehind closed doors, critical disputes are won and lost in a struggle forsurvival.Inflection Point is a fast-paced, high-stakes legal thriller and memoir.But it is also a cautionary tale posing a question as fundamental as itis critical: Have the efforts to bring affordable medicines to consumershelped to cripple the very industry that invents life-saving drugs in thefirst place?